Authors

Shelley-Ann M. Girwar, MSc
Latest Article

Identifying Complex Patients Using Adjusted Clinical Groups Risk Stratification Tool

In this study, the authors developed a method for use in primary care to identify a group of patients with complex care needs using Aggregated Diagnosis Groups.

Matthew W. Reynolds, PhD

Matthew W. Reynolds, PhD, is Vice President, Real World Evidence, IQVIA

Latest Article

Combatting COVID-19 With Real-World Evidence

A vaccine isn’t the panacea many assume it will be. Even when it becomes available, the virus won’t go away. Real world evidence will be needed to guide decision making.

Molly Moore Jeffery, PhD, MPP
Latest Article

Provider Barriers in Uptake of Biosimilars: Case Study on Filgrastim

Previous studies have found modest uptake of biosimilars in both commercial and Medicare populations. This study finds that the uptake varies between the rural and urban provider settings.

Akshara Kumar, PharmD
Latest Article

Institutional Practices for Charitable Medication Access for Uninsured Patients

Analysis of a patient sample enrolled in charitable care at an academic medical center revealed that chronic medications were variably filled at a significant cost.

Sarah E. Messiah, PhD
Latest Article

Timely Preterm-Birth Prediction Among Pregnant Women in Medicaid Without Preterm-Birth History

A novel prediction model is developed that accurately predicts preterm birth in a timely manner among pregnant women in Medicaid without preterm-birth history.

Fadoua El Moustaid, PhD
Latest Article

Real-World Value of Direct-Acting Antivirals for Hepatitis C at Kaiser Permanente Southern California

This analysis demonstrates value and innovation of direct-acting antivirals for the treatment of chronic hepatitis C in the US Kaiser Permanente health system.

Stephen Lott, PharmD, MS
Latest Article

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.

Dhruv Chopra, MS
Latest Article

Better Together? Costs of First-line Chemoimmunotherapy for Advanced Non–Small Cell Lung Cancer

Compared with first-line immunotherapy or chemotherapy alone, combination chemoimmunotherapy for advanced/metastatic non–small cell lung cancer has significantly higher antineoplastic drug and associated medical costs.

Elliot B. Tapper, MD
Latest Article

Baffled by NAFLD: The Horse Might Be Out of the Barn but Should Not Take Us for a Ride

As awareness of nonalcoholic fatty liver disease (NAFLD) rises, it is essential to develop and implement a rigorously determined approach to identify patients who will, or will not, benefit from diagnostic evaluation.

Jennifer L. Bright, MPA
Latest Article

Overhauling Quality Measurement in the US: Measure What Matters

As the US charts its course through the next political era, it is crucial that we boldly allocate resources and prioritize what truly impacts patients. When faced with complexity, feasibility concerns, or entrenched norms, we must proclaim: “It’s the outcomes, stupid.”

Meena Venkatachalam, MSc

Meena Venkatachalam, MSc, is the senior director of Health Economics at PRECISIONheor.

Latest Article

Contributor: Steps Health Professionals Can Take to Reduce Inequality in Health Outcomes

Jason Shafrin, PhD, serves as the vice president of Health Economics at PRECISIONheor, and Meena Venkatachalam, MSc, is the senior director of Health Economics at PRECISIONheor.

Alison Galbraith, MD, MPH
Latest Article

Impact of the COVID-19 Pandemic on Regular Emergency Department Users

Regular users of the emergency department (ED) transiently reduced ED visits when faced with ED access barriers during the COVID-19 pandemic.

Kaitlyn Bader
Latest Article

Addressing the Psychosocial Impacts of Inflammatory Skin Conditions in Patient Care

Lauren Miller, PA-C, kicked off the inaugural 2023 Inflammatory Disease Summit by discussing the psychosocial impacts related to atopic dermatitis, psoriasis, and hidradenitis suppurativa.

Areeba Kara, MD
Latest Article

Inpatient Opioid Receipt and Care Experiences for Vaginal Delivery

The objective of this study was to examine the relationship between inpatient opioid receipt and care experiences of women hospitalized for vaginal delivery.

Matthew Collins, MD, MBA
Latest Article

Long-Term Health Care Costs Following COVID-19: Implications for Pandemic Preparedness

A difference-in-differences analysis of health care claims data evaluated excess health care costs in the 12 months following COVID-19 diagnosis among the general and older adult populations.

Claudia Uribe, MD
Latest Article

Post-SNF Outcomes and Cost Comparison: Medicare Advantage vs Traditional Medicare

Patients enrolled in Medicare Advantage had better outcomes and lower cost following skilled nursing facility (SNF) discharge than patients enrolled in traditional fee-for-service Medicare.

Jonathan Arnold, MD, MS, MSE
Latest Article

Empiric Segmentation of High-risk Patients: A Structured Literature Review

Data-driven segmentation of high-risk patient populations may inform health system interventions, but results are dependent on the data sources and methods applied.

Megan Peter, PhD
Latest Article

Rheumatoid Arthritis Medication Adherence in a Health System Specialty Pharmacy

Integrated health system specialty pharmacies provide specialized services to patients, resulting in high rates of adherence to and financial assistance with specialty disease-modifying antirheumatic drugs.

Kathryn R. Brignole, MS
Latest Article

Prevalence and Inclusiveness of Pay-for-Performance Incentives for HPV Vaccination

This article examines the prevalence of pay-for-performance incentives to promote human papillomavirus vaccination and other quality metrics as reported by frontline clinical staff.

Johnie Rose, MD, PhD
Latest Article

Investigators Advocate for Ongoing Comparison of Cancer Outcomes Among MA, FFS Beneficiaries

Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD, of Case Western Reserve University, acknowledge key limitations of their study and prioritize areas for further research.

Jennifer Baron
Jennifer Baron

Jennifer Baron is focused on how federal and state policy can drive value-based, dignified care for underserved populations. She currently leads policy efforts for Cityblock Health, a value-based provider and innovator serving communities with complex needs. She was previously a Senior Advisor with the Centers for Medicare & Medicaid Services, where she designed and implemented state demonstrations to integrate care for individuals dually eligible for Medicare and Medicaid.

Latest Article

Contributor: In a Fast-Growing and Competitive Dual-Eligible Market, Trust Will Be a Critical Differentiator

Building trust with patients who are dually eligible for Medicaid and Medicare can help to improve their lives as they navigate receiving care to address their clinical and behavioral health needs.

Crystal Harris, MPH
Latest Article

Considerations to Increase Rates of Breast Cancer Screening Across Populations

Authors from the Community Oncology Alliance and Avalere Health present data that show breast cancer screening rates recovered more slowly among some racial/ethnic groups following on the onset of the COVID-19 pandemic.

Osayande Osagiede, MBBS, MPH
Latest Article

Impact of Travel Distance on Quality Outcomes in Colorectal Cancer

This study identified characteristics of patients with colorectal cancer who traveled farther for surgery and found that those who traveled tended to stay longer at the hospital.

Chad Stecher, PhD
Latest Article

Cost Savings From an mHealth Tool for Improving Medication Adherence

The Wellth smartphone app significantly increased medication adherence and lowered unnecessary health care utilization and costs over 9 months among Medicaid beneficiaries who were self-managing chronic conditions.

H. Shelton Brown, PhD
Latest Article

Reimbursement for Genetic Variant Reinterpretation: Five Questions Payers Should Ask

Periodic reinterpretation of genetic sequencing results presents a challenge for developing transparent and systematic coverage and reimbursement policies.

Ninfa Candela, MD
Latest Article

Outcomes in Patients With IBD Stratified by Risk of Disease Progression

This study validates criteria to identify patients with inflammatory bowel disease (IBD) at risk of worsening disease who may benefit from early treatment with advanced therapies.

Andrei Racila, BS
Latest Article

Service Line Care Delivery Model for COVID-19 Patient-Centric Care

The authors provide steps hospitals can take to align their care delivery model to effectively meet the demands of a public health crisis such as the current pandemic.

Zahoor Elahi, MS
Latest Article

Machine Intelligence for Early Targeted Precision Management and Response to Outbreaks of Respiratory Infections

This paper evaluates novel machine intelligence to predict patients at risk of severe respiratory infections and recommend postacute care providers likely to reduce infection risk.

Pelin Ozluk, PhD
Latest Article

Trends in Low-Value Cancer Care During the COVID-19 Pandemic

Among adults with newly diagnosed cancer, rates of low-value cancer services persisted throughout the COVID-19 pandemic in areas ranging from peridiagnosis imaging to end-of-life care.

Ahmed Shelbaya, MD
Latest Article

Real-world Usage of Bevacizumab-bvzr Biosimilar in US Oncology Practice

Real-world adoption of bevacizumab-bvzr biosimilar was retrospectively assessed, revealing switching between biosimilars and the reference product and utilization in extrapolated indications and combination regimens.
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text